Sarah Smith
Endocrinology, Diabetes & Metabolism · Maryville, TNNPI 1477871689
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,625 of the $19,674 with a category attached, or 74.3%. Lilly USA, LLC accounts for 95.0% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $12,907 and has fallen 99.9% since, to $15 in 2025.
Across 120 payments — averaging $163.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$19K
- Abbott$198
- Novo Nordisk$133
- Amgen$118
- Sanofi-aventis U.S. LLC$108
- Johnson & Johnson$58
- plus $376 from 16 others
What the payments were for
- Speaking & faculty fees$14,62574%
- Travel & lodging$3,35417%
- Food & beverage$1,6809%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 69 | $18,682 |
| Abbott | 4 | $198 |
| Novo Nordisk | 8 | $133 |
| Amgen(2 entities) | 7 | $118 |
| Sanofi-aventis U.S. LLC | 6 | $108 |
| Johnson & Johnson(2 entities) | 3 | $58 |
| IBSA Pharma Inc. | 3 | $44 |
| Corcept Therapeutics | 2 | $38 |
| Insulet Corporation | 2 | $33 |
| Shire North American Group Inc | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $29 |
| Bayer | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 1 | $23 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| AbbVie | 1 | $19 |
| Medtronic | 1 | $18 |
| Pfizer | 1 | $17 |
| EMD Serono, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Companion Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HUMULIN$14,625
- TRULICITY$322
- CARDIOMEMS$143
How this compares
$19,674 in reported general payments places this provider in the 75th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
See all endocrinology, diabetes & metabolism providers in Tennessee →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 22 | $1,811 |
| Hydrocortisone | 12 | $843 |
| Levothyroxine Sodium | 44 | $343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $19 | $1,81122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 130 endocrinology, diabetes & metabolism providers in Tennessee.
Other endocrinology, diabetes & metabolism in Maryville
- Aaron BusseyMaryville$35K
- Alan CohenMemphis$1.4M
- Craig WierumNashville$1.3M
- Pascal DauphinHendersonville$925K
- Shimon HararyMemphis$735K
- Lisa MyersGermantown$609K
- Amit VoraKnoxville$579K
- Terri JerkinsNashville$567K
- Samuel Dagogo-JackMemphis$407K
- Michael CarlsonNashville$381K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.